CA3298230A1 - Formulations de composés d'acide nucléique et leurs utilisations - Google Patents

Formulations de composés d'acide nucléique et leurs utilisations

Info

Publication number
CA3298230A1
CA3298230A1 CA3298230A CA3298230A CA3298230A1 CA 3298230 A1 CA3298230 A1 CA 3298230A1 CA 3298230 A CA3298230 A CA 3298230A CA 3298230 A CA3298230 A CA 3298230A CA 3298230 A1 CA3298230 A1 CA 3298230A1
Authority
CA
Canada
Prior art keywords
formulations
nucleic acid
acid compounds
compounds
nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3298230A
Other languages
English (en)
Inventor
Adel Rafai Far
Rajeshwar Motheram
Jasmin MONPARA
Original Assignee
Comanche Biopharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Comanche Biopharma Corp filed Critical Comanche Biopharma Corp
Publication of CA3298230A1 publication Critical patent/CA3298230A1/fr
Pending legal-status Critical Current

Links

CA3298230A 2023-07-13 2024-07-11 Formulations de composés d'acide nucléique et leurs utilisations Pending CA3298230A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/513,429 2023-07-13

Publications (1)

Publication Number Publication Date
CA3298230A1 true CA3298230A1 (fr) 2025-01-16

Family

ID=

Similar Documents

Publication Publication Date Title
CA3310102A1 (en) Enzyme Formulations and Reaction Mixtures for Nucleic Acid Amplification
CA3271180A1 (fr) Formulations d'arn de gène d'intérêt
EP4071163A4 (fr) Complexe d'acide nucléique et composition pharmaceutique le contenant
HK40116956A (en) Nucleic acid compositions and uses thereof
CA3291219A1 (fr) Formulations de pectolinarigénine
CA3275414A1 (fr) Compositions d'aide à la granulation et procédés d'utilisation
HK40125914A (en) Compositions and methods for nucleic acid modifications
CA3310214A1 (fr) Formulation liquide d'arn
HK40117787A (en) Stable formulations of shr0302
HK40118479A (en) Nucleic acid construct and use thereof
AU2024247902A1 (en) Compositions and methods for nucleic acid sequencing
HK40125874A (en) Compositions and methods for nucleic acid sequencing
CA3261850A1 (fr) Compositions d'acide 3,5-diiodothyropropionique et leurs méthodes d'utilisation
CA3291292A1 (fr) Formes polymorphes et formulations de leriglitazone
HK40122888A (en) Pharmaceutical formulations of bictegravir and lenacapavir
CA3301254A1 (fr) Formulations d'ériodictyol
HK40112689A (en) Formulations of radiprodil
HK40087324A (en) Novel combination of nucleic acid regulatory elements and methods and uses thereof
HK40128325A (zh) 通用t细胞和组合物及它们的使用方法
CA3296099A1 (fr) Formulation solide de pudafensine à administrer par voie orale
CA3287251A1 (fr) Commutateurs d'arrêt d'acides nucléiques et procédés et utilisations de ceux-ci
HK40111054A (en) Enzyme formulations and reaction mixtures for nucleic acid amplification
HK40117106A (en) Solid forms of resiquimod and formulations thereof
HK40119217A (en) Nucleic acid construct comprising utr and use thereof
HK40094676A (en) Methods and compositions for nucleic acid sequencing